Atlas Trials

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD

Clinical trial NCT01855334 · WITHDRAWN

Trial details

NCT number
NCT01855334
Sponsor
Brigham and Women's Hospital
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
End Stage Renal DiseaseHemodialysis
Start date
2013-09-01
Primary completion
2018-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.